(Q37947916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

meta-analysis

0 references

title

Is gene array testing to be considered routine now? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Soonmyung Paik

series ordinal

1

1 reference

25 August 2017

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

20 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

S87-91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

Molecular portraits of human breast tumours

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Breast cancer prognostic classification in the molecular era: the role of histological grade

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Concordance among gene-expression-based predictors for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Genomic grade index is associated with response to chemotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Gene-expression-based prognostic assays for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Use of archived specimens in evaluation of prognostic and predictive biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

TAILORx: trial assigning individualized options for treatment (Rx)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970301-0

7 January 2021

10.1016/S0960-9776(11)70301-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015300%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference